Latest News & Updates

Breaking News

  • 7 minutes ago

  • Pharma Now Editorial Team

Lupin Gains China Approval for Oseltamivir Oral Suspension via Yabao Pharmaceuticals Partnership
Breaking News
Venus Remedies Gains Saudi SFDA Approval for Plerixafor Specialty Injectable in GCC Market

Pharma Now Editorial Team

Other trending news you may like to read

Lupin Gains China Approval for Oseltamivir Oral Suspension via Yabao Pharmaceuticals Partnership

Lupin secures NMPA approval for Oseltamivir oral suspension in China through a co-development partnership with Yabao Pharmaceuticals.

Pharma Now Editorial Team

Pharma Now

Venus Remedies Gains Saudi SFDA Approval for Plerixafor Specialty Injectable in GCC Market

Venus Remedies secures SFDA approval for Plerixafor, marking entry into GCC specialty oncology injectables and raising the bar on site qualification strategy.

Pharma Now Editorial Team

Pharma Now

FDA Grants Differin Epiduo Rx-to-OTC Switch, Expanding Adapalene-Benzoyl Peroxide Access

FDA approves Differin Epiduo for OTC use under NDA 220736, triggering labeling, validation, and packaging compliance obligations for manufacturers.

Pharma Now Editorial Team

Pharma Now

Boehringer Ingelheim Gains CHMP Positive Opinion for Nerandomilast in IPF and PPF

CHMP issues positive opinion for Boehringer Ingelheim's nerandomilast in IPF and PPF, advancing EU approval for the first new fibrosis therapy in over a decade.

Pharma Now Editorial Team

Pharma Now